Owlstone Medical
Trending Articles
Related Content
Regulatory
Breath Biopsy Platform integrated into GSK’s clinical trial
The phase II respiratory disease clinical trial will analyse breath biomarkers to improve understanding of the treatment effects of a novel GlaxoSmithKline (GSK) pipeline drug candidate for chronic obstructive pulmonary disease (COPD)